Personalized cancer vaccines

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

217 papers

Showing 169-180 of total 217 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2023CrossrefSupporting evidence69 citations

Ryan C. Augustin; Riyue Bao; Jason J. Luke

Feb 1, 2023Journal for ImmunoTherapy of Cancer

2023OpenAlexDirectly related993 citations

Neoantigens: promising targets for cancer therapy

Na Xie; Guobo Shen; Wei Gao; Zhao Huang; Canhua Huang; Li Fu

Jan 5, 2023Signal Transduction and Targeted Therapy

2022OpenAlexDirectly related419 citations

Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 <sup>+</sup> T cell response

Jinjin Chen; Zhongfeng Ye; Changfeng Huang; Min Qiu; Donghui Song; Yamin Li; Qiaobing Xu

Aug 15, 2022Proceedings of the National Academy of Sciences

2022CrossrefDirectly related24 citations

Application of mRNA Technology in Cancer Therapeutics

Yesim Eralp

Aug 5, 2022Vaccines

2022OpenAlexDirectly related190 citations

Nanocarriers based on bacterial membrane materials for cancer vaccine delivery

Xiao Zhao; Ruifang Zhao; Guangjun Nie

Jul 25, 2022Nature Protocols

2022OpenAlexDirectly related86 citations

The current clinical landscape of personalized cancer vaccines

Hajer Fritah; Raphaël Rovelli; Cheryl Lai-Lai Chiang; Lana E. Kandalaft

Mar 24, 2022Cancer Treatment Reviews

2022OpenAlexDirectly related162 citations

mRNA cancer vaccines: Advances, trends and challenges

Qing He; Hua Gao; Dejiang Tan; Heng Zhang; Junzhi Wang

Mar 23, 2022Acta Pharmaceutica Sinica B

2022OpenAlexDirectly related714 citations

Cancer vaccines as promising immuno-therapeutics: platforms and current progress

Jian Liu; Minyang Fu; Manni Wang; Dandan Wan; Yuquan Wei; Xiawei Wei

Mar 18, 2022Journal of Hematology & Oncology

2022CrossrefDirectly related32 citations

Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies

Carson R. Reynolds; Son Tran; Mohit Jain; Aru Narendran

Jan 26, 2022Vaccines

2022OpenAlexDirectly related59 citations

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma

Sofie Kirial Mørk; Mohammad Kadivar; Kalijn Fredrike Bol; Arianna Draghi; Marie Christine Wulff Westergaard; Signe Koggersbøl Skadborg; Nana Overgaard; Anders Bundgård Sørensen; Ida Svahn Rasmussen; Lars Vibe Andreasen; Christina Westmose Yde; Thomas Trolle; Christian Garde; Jens Friis-Nielsen; Nis Nørgaard; Dennis Christensen; Jens Vindahl Kringelum; Marco Donia; Sine Reker Hadrup; Inge Marie Svane

Jan 10, 2022OncoImmunology

2022OpenAlexDirectly related32 citations

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma

Mona O. Mohsen; Daniel E. Speiser; Justine Michaux; HuiSong Pak; Brian J. Stevenson; Monique Vogel; Varghese Inchakalody; Simone de Brot; Said Dermime; George Coukos; Michal Bassani‐Sternberg; Martin F. Bachmann

Jan 1, 2022Journal for ImmunoTherapy of Cancer

2021OpenAlexDirectly related125 citations

Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion

Zhixiong Cai; Xiaoping Su; Liman Qiu; Zhenli Li; Xiaolou Li; Xiuqing Dong; Fuqun Wei; Yang Zhou; Liuping Luo; Geng Chen; Hengkai Chen; Yingchao Wang; Yongyi Zeng; Xiaolong Liu

Dec 1, 2021Molecular Cancer